Burcin Gonul Iremli

Burcin Gonul Iremli

Auto-generated profile, based on publicly available information

Burcin Gonul Iremli

Department of Endocrinology and Metabolism, Hacettepe University School of Medicine, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2023 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
İEİmdat Eroglu
İmdat Eroglu
BIBurcin Gonul Iremli
Burcin Gonul Iremli
IIIlkay Idilman
Ilkay Idilman
DYDeniz Yuce
Deniz Yuce
İLİNCİLAY LAY
İNCİLAY LAY
TETomris Erbas
Tomris Erbas
Context Nonalcoholic fatty liver disease (NAFLD) is a metabolical disorder and can lead to liver fibrosis. Because it is commonly seen, several noninvasive scores (NS) have been validated to identify high-risk patients. Patients with NAFLD have been shown to have higher serum angiopoietin-like protein-8 (ANGPTL-8) levels. Objective The risk of NAFLD is known insufficiently in acromegaly. Moreover, the utility of the NS and the link between NAFLD and ANGPTL-8 in acromegaly is unknown. Methods Thirty-two patients with acromegaly (n = 15, active [AA] and n = 17, controlled acromegaly [CA]) and 19 healthy controls were included. Magnetic resonance imaging (MRI)-proton density fat fraction (PDFF) was used to evaluate hepatic steatosis, and magnetic resonance elastography to evaluate liver stiffness measurement. ANGPTL-8 levels were measured with ELISA. Results Median liver MRI-PDFF and NAFLD prevalence in AA were lower than in CA (P = .026 and P < .001, respectively). Median magnetic resonance elastography-liver stiffness measurement were similar across groups. Of the NS, visceral adiposity index, fatty liver index, hepatic steatosis index, and triglyceride-glucose index (TyG) all showed positive correlation with the liver MRI-PDFF in the control group. However, only TyG significantly correlated with liver fat in the AA and CA groups. There was no correlation between traditional NAFLD risk factors (body mass index, waist circumference, C-reactive protein, homeostasis model assessment for insulin resistance, visceral adipose tissue) and liver MRI-PDFF in the AA and CA. Patients with acromegaly with NAFLD had lower GH, IGF-1, and ANGPTL-8 levels than in those without NAFLD (P = .025, P = .011, and P = .036, respectively). Conclusion Active acromegaly may protect from NAFLD because of high GH. In patients with acromegaly, NAFLD risk cannot be explained with classical risk factors; hence, additional risk factors must be identified. TyG is the best score to evaluate NAFLD risk. Lower ANGPTL-8 in patients with acromegaly and NAFLD implies this hormone may be raised because of insulin resistance rather than being a cause for NAFLD.


22 February 2024 in Journal of Clinical Densitometry
Verified
Journal Article
Closed access
İEİmdat Eroglu
İmdat Eroglu
BIBurcin Gonul Iremli
Burcin Gonul Iremli
AEAysegul Erkoc
Aysegul Erkoc
IIIlkay Idilman
Ilkay Idilman
DYDeniz Yuce
Deniz Yuce
TETomris Erbas
Tomris Erbas

21 December 2020 in Ulusal Romatoloji Dergisi
Verified
Journal Article
Closed access
DKDuygu Temiz Karadağ
Duygu Temiz Karadağ
BGBurçin Gönül
Burçin Gönül
ÖIÖzlem Özdemir Işık
Özlem Özdemir Işık
STSenem Tekeoglu
Senem Tekeoglu
AYAyten Yazıcı
Ayten Yazıcı
ACAyşe Cefle
Ayşe Cefle

27 December 2023 in Acta Medica
Verified
Journal Article
Open access
PDF file
MEMehmet Erdevir
Mehmet Erdevir
BEBanu Evranos
Banu Evranos
SOSeda Hanife Oğuz
Seda Hanife Oğuz
SZSamuray Zekeriyev
Samuray Zekeriyev
BIBurçin Gönül İrEmli
Burçin Gönül İrEmli
AGAlper Gürlek
Alper Gürlek
Objective: Vitamin D affects heart muscle contraction through its direct and indirect effects on calcium and phosphorus metabolism. We aimed to investigate N-terminal pro-brain natriuretic peptide, high-sensitive troponin-I, galectin-3, fibroblast growth factor-23, suppression of tumorigenesis-2, and parathormone levels concerning Vitamin-D status in patients with heart failure with preserved systolic function. Materials and Methods: Seventy-one patients diagnosed with heart failure with preserved ejection fraction and 61 healthy individuals as a control group were enrolled in the study. The relation between vitamin-D level and heart failure with preserved ejection and the determination of cut-off levels of all parameters was evaluated using ROC and logistic regression analyses. Results: While vitamin-D levels in the patient group were lower than the controls (median 14.5 vs. 21.11 ng/ml, P=0.002), N-terminal pro-brain natriuretic peptide, galectin-3, suppression of tumorigenesis-2 and parathormone levels in the patient group were significantly higher. The area under the curve values of these four elevated markers in the ROC analysis was significant for the diagnosis of heart failure with preserved ejection fraction. In the logistic regression analysis, a one-unit decrease in vitamin-D increased the risk of having heart failure with preserved systolic function 1,084 times, while a 10-unit categorical decrease in vitamin-D increased the risk 2,27 times. In the patient group, the area under the curves for N-terminal pro-brain natriuretic peptide, galectin-3, suppression of tumorigenesis-2 and parathormone were higher when vitamin-D was >20 ng/ml compared to the group with vitamin-D < 20 ng/ml. Conclusions: N-terminal pro-brain natriuretic peptide, galectin-3, suppression of tumorigenesis-2 and parathormone were affected by the vitamin-D status in determining heart failure with preserved systolic function, with increased detection capability when vitamin-D is >20 ng/ml.